My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Correo Científico Médico
On-line version ISSN 1560-4381
Abstract
LOPEZ RIOS, Leanet; SANCHEZ MONTERO, Israel Rolando and GARCIA MORENO, Idania. Relation between Prostate Specific Antigen Tumoral Marker and Prostate Cancer Mortality. ccm [online]. 2017, vol.21, n.1, pp. 100-111. ISSN 1560-4381.
Introduction: the prostate specific antigen (PSA) is a specific tumor marker for the of prostate cancer diagnosis. By using jointly the value of the PSA and the rectal touch, though it more than 60% of the prostate cancer can be diagnose. Thus the mortality in the studied population, notably decreases Objectives: to evaluate quantitatively and qualitatively, the use of prostate specific antigen taking into account the health areas and popular councils with greater number of deceased. Method: the universe comprised 131 deceased patients reported by the Department of Provincial Statistics; the registration of samples of the Laboratory SUMA of Rafael Freyre Torres municipality was used as a data source. The results are reflected in tables and graphs in which absolute and relative frequency distributions (percentages and rates) are used. Results: the rate of annual half mortality of the Municipality was 28.6 x 100 000 men. The areas of more risk of dying for prostate cancer were: the health area of Santa Lucía and popular council Carlos Noris, Fray Benito and Santa Lucía with annual rates of half mortality of (30.0), (48.8), (33.1) and (31.3) x 100 000 men respectively and the territories that made the best use of the PSA were: Santa Lucia health area and popular councils (69.0), (97.0), (93.4) and (61.6) tests per 1000 men, respectively. Conclusions: the mortality due to prostate cancer presented a progressive increase in the last seventeenth years. Since Fray Benito is a very affected area, it is necessary to direct the investigations to the PSA use as method for prostate cancer diagnosis.
Keywords : prostate specific antigen; mortality; prostate cancer.